Learn More
BACKGROUND S-propargyl-cysteine (SPRC), an H(2)S donor, is a structural analogue of S-allycysteine (SAC). It was investigated for its potential anti-cancer effect on SGC-7901 gastric cancer cells and the possible mechanisms that may be involved. METHODS AND FINDINGS SPRC treatment significantly decreased cell viability, suppressed the proliferation and(More)
  • 1